← Open Payments lookup

EMILY BROZGAL: Open Payments

NPI 1881018265 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,397 in 59 payments from 15 companies in 2025. Trend: 2023 $21 · 2024 $253 · 2025 $1,397

Food & beverage: $1,397
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$263
Teva Pharmaceuticals USA, Inc.3$149
Neurocrine BioSciences, Inc.8$149
Alkermes, Inc.7$130
Lundbeck LLC5$119
Otsuka America Pharmaceutical, Inc.5$112
ABBVIE INC.4$99
Takeda Pharmaceuticals U.S.A., Inc.5$97
Axsome Therapeutics, Inc.4$84
E.R. Squibb & Sons, L.L.C.3$78

Products named: CAPLYTA, REXULTI, INGREZZA, ARISTADA, UZEDY, VRAYLAR, TRINTELLIX, Auvelity.

Industry payments across TX — which companies pay providers there.